Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biologics

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1496068

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1496068

Synthetic Biology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

According to Fairfield Market Research's latest report, the global synthetic biology market is poised to experience exponential growth. By 2024, the market is expected to reach USD 21 billion, and by the end of 2031, it is projected to attain a valuation of USD 150 billion, growing at a compound annual growth rate (CAGR) of 32%.

Driving Factors

The growth of the synthetic biology market is being driven by several key factors:

1.Advancements in Genome Editing: Technologies such as CRISPR have revolutionized synthetic biology, enabling more precise and efficient editing of genetic material. This has facilitated the development of new biopharmaceuticals and agricultural products.

2.Increasing Investments: There has been a significant rise in R&D funding and investment in synthetic biology from both public and private sectors. Government agencies, research institutions, and large corporations are heavily investing in this field, further propelling market growth.

3.Reduced DNA Sequencing Costs: The cost of DNA sequencing and synthesis has decreased significantly, making it more accessible and encouraging broader adoption across various industries.

Key Market Segments

Healthcare Sector Dominance

The healthcare sector remains the largest revenue-generating segment within the synthetic biology market. It is expected to grow at a CAGR of 30% during the forecast period. This growth is attributed to the increasing application of synthetic biology in the development of biopharmaceuticals, gene therapies, and other medical innovations.

Agriculture and Food Yield Improvement

Synthetic biology is playing a crucial role in agriculture, especially in the development of high-yield crops and advanced pest management techniques. The technology aids in addressing the challenges posed by a growing global population and changing dietary habits, contributing to improved nutrition and food security.

Regional Insights

North America Leading the Market

North America is the largest market for synthetic biology, accounting for over 35% of the global market share. The region's market is expected to grow significantly over the forecast period. Factors driving this growth include the presence of well-established synthetic biology companies, extensive academic research, and substantial R&D investments.

U.S. Market Analysis

In the U.S., the synthetic biology market is a major contributor to the global market's expansion. The U.S. accounted for over 28% of the market share and is expected to grow significantly over the forecast period. The country's market growth is supported by favorable regulatory frameworks, government support, and significant private sector investments.

Japan's Rapid Growth

The synthetic biology market in Japan is anticipated to grow at a remarkable rate . The market is expected to provide significant opportunities, reaching a substantial valuation. This growth is driven by advancements in healthcare infrastructure, an aging population, and increasing investments in medical research and development.

Competitive Analysis

The synthetic biology market is highly competitive, with major players adopting strategies such as collaborations, joint ventures, and new product launches to strengthen their market position. Some of the key companies profiled in the report include:

  • Bota Biosciences
  • Codexis, Inc.
  • Creative Biogene
  • Creative Enzymes
  • EnBiotix, Inc.
  • Eurofins Scientific
  • Illumina
  • Merck
  • New England Biolabs
  • Novozymes
  • Pareto Biotechnologies, Inc.
  • Scarab Genomics
  • Synthego
  • Synthetic Genomics
  • Thermo Fisher

Recent Developments

1.Ribbon Biolabs' Funding: In January 2022, Ribbon Biolabs raised 18 million Euros in Series A funding to build commercial-scale manufacturing plants and expand its DNA synthesis techniques across the United States.

2.Bota Bioscience's Investment: In August 2021, Bota Bioscience secured USD 100 million in Series B funding to advance its sustainable biomanufacturing program.

Global Synthetic Biology Market Segmentation:

By Application

  • Healthcare
    • Clinical
    • Non-Clinical Research
  • Non-Healthcare
    • Biotech Crops
    • Speciality Chemicals
    • Bio-Fuels

By Product Type

  • Oligonucleotide/Oligo pools and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Xeno-nucleic Acids
  • Chassis Organism

By Technology

  • NGS
  • PCR
  • Genome Editing
  • Bioprocessing Technology
  • Other Technologies

By End-use

  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Other End-uses

By Region type

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

"

Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Synthetic Biology Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Synthetic Biology Market Outlook, 2019 - 2031

  • 3.1. Global Synthetic Biology Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Healthcare
        • 3.1.1.1.1. Clinical
        • 3.1.1.1.2. Non-Clinical Research
      • 3.1.1.2. Non-Healthcare
        • 3.1.1.2.1. Biotech Crops
        • 3.1.1.2.2. Speciality Chemicals
        • 3.1.1.2.3. Bio-Fuels
  • 3.2. Global Synthetic Biology Market Outlook, By Product Type, Value (US$ Bn), 2019 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Oligonucleotide/Oligo pools and Synthetic DNA
      • 3.2.1.2. Enzymes
      • 3.2.1.3. Cloning Technologies Kits
      • 3.2.1.4. Xeno-nucleic Acids
      • 3.2.1.5. Chassis Organism
  • 3.3. Global Synthetic Biology Market Outlook, By Technology, Value (US$ Bn), 2019 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. NGS
      • 3.3.1.2. PCR
      • 3.3.1.3. Genome Editing
      • 3.3.1.4. Bioprocessing Technology
      • 3.3.1.5. Other Technologies
  • 3.4. Global Synthetic Biology Market Outlook, By End-use, Value (US$ Bn), 2019 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Biotechnology & Pharmaceutical Companies
      • 3.4.1.2. Academic & Government Research Institutes
      • 3.4.1.3. Other End-uses
  • 3.5. Global Synthetic Biology Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Synthetic Biology Market Outlook, 2019 - 2031

  • 4.1. North America Synthetic Biology Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Healthcare
        • 4.1.1.1.1. Clinical
        • 4.1.1.1.2. Non-Clinical Research
      • 4.1.1.2. Non-Healthcare
        • 4.1.1.2.1. Biotech Crops
        • 4.1.1.2.2. Speciality Chemicals
        • 4.1.1.2.3. Bio-Fuels
  • 4.2. North America Synthetic Biology Market Outlook, By Product Type, Value (US$ Bn), 2019 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Oligonucleotide/Oligo pools and Synthetic DNA
      • 4.2.1.2. Enzymes
      • 4.2.1.3. Cloning Technologies Kits
      • 4.2.1.4. Xeno-nucleic Acids
      • 4.2.1.5. Chassis Organism
  • 4.3. North America Synthetic Biology Market Outlook, By Technology, Value (US$ Bn), 2019 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. NGS
      • 4.3.1.2. PCR
      • 4.3.1.3. Genome Editing
      • 4.3.1.4. Bioprocessing Technology
      • 4.3.1.5. Other Technologies
  • 4.4. North America Synthetic Biology Market Outlook, By End-use, Value (US$ Bn), 2019 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Biotechnology & Pharmaceutical Companies
      • 4.4.1.2. Academic & Government Research Institutes
      • 4.4.1.3. Other End-uses
  • 4.5. North America Synthetic Biology Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 4.5.1.2. U.S. Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 4.5.1.3. U.S. Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 4.5.1.4. U.S. Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 4.5.1.5. Canada Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 4.5.1.6. Canada Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 4.5.1.7. Canada Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 4.5.1.8. Canada Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
    • 4.5.2. Market Attractiveness Analysis

5. Europe Synthetic Biology Market Outlook, 2019 - 2031

  • 5.1. Europe Synthetic Biology Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Healthcare
        • 5.1.1.1.1. Clinical
        • 5.1.1.1.2. Non-Clinical Research
      • 5.1.1.2. Non-Healthcare
        • 5.1.1.2.1. Biotech Crops
        • 5.1.1.2.2. Speciality Chemicals
        • 5.1.1.2.3. Bio-Fuels
  • 5.2. Europe Synthetic Biology Market Outlook, By Product Type, Value (US$ Bn), 2019 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Oligonucleotide/Oligo pools and Synthetic DNA
      • 5.2.1.2. Enzymes
      • 5.2.1.3. Cloning Technologies Kits
      • 5.2.1.4. Xeno-nucleic Acids
      • 5.2.1.5. Chassis Organism
  • 5.3. Europe Synthetic Biology Market Outlook, By Technology, Value (US$ Bn), 2019 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. NGS
      • 5.3.1.2. PCR
      • 5.3.1.3. Genome Editing
      • 5.3.1.4. Bioprocessing Technology
      • 5.3.1.5. Other Technologies
  • 5.4. Europe Synthetic Biology Market Outlook, By End-use, Value (US$ Bn), 2019 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Biotechnology & Pharmaceutical Companies
      • 5.4.1.2. Academic & Government Research Institutes
      • 5.4.1.3. Other End-uses
  • 5.5. Europe Synthetic Biology Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 5.5.1.2. Germany Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 5.5.1.3. Germany Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 5.5.1.4. Germany Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 5.5.1.5. U.K. Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 5.5.1.6. U.K. Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 5.5.1.7. U.K. Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 5.5.1.8. U.K. Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 5.5.1.9. France Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 5.5.1.10. France Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 5.5.1.11. France Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 5.5.1.12. France Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 5.5.1.13. Italy Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 5.5.1.14. Italy Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 5.5.1.15. Italy Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 5.5.1.16. Italy Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 5.5.1.17. Turkey Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 5.5.1.18. Turkey Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 5.5.1.19. Turkey Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 5.5.1.20. Turkey Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 5.5.1.21. Russia Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 5.5.1.22. Russia Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 5.5.1.23. Russia Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 5.5.1.24. Russia Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 5.5.1.25. Rest of Europe Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 5.5.1.26. Rest of Europe Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 5.5.1.27. Rest of Europe Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 5.5.1.28. Rest of Europe Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
    • 5.5.2. Market Attractiveness Analysis

6. Asia Pacific Synthetic Biology Market Outlook, 2019 - 2031

  • 6.1. Asia Pacific Synthetic Biology Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Healthcare
        • 6.1.1.1.1. Clinical
        • 6.1.1.1.2. Non-Clinical Research
      • 6.1.1.2. Non-Healthcare
        • 6.1.1.2.1. Biotech Crops
        • 6.1.1.2.2. Speciality Chemicals
        • 6.1.1.2.3. Bio-Fuels
  • 6.2. Asia Pacific Synthetic Biology Market Outlook, By Product Type, Value (US$ Bn), 2019 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Oligonucleotide/Oligo pools and Synthetic DNA
      • 6.2.1.2. Enzymes
      • 6.2.1.3. Cloning Technologies Kits
      • 6.2.1.4. Xeno-nucleic Acids
      • 6.2.1.5. Chassis Organism
  • 6.3. Asia Pacific Synthetic Biology Market Outlook, By Technology, Value (US$ Bn), 2019 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. NGS
      • 6.3.1.2. PCR
      • 6.3.1.3. Genome Editing
      • 6.3.1.4. Bioprocessing Technology
      • 6.3.1.5. Other Technologies
  • 6.4. Asia Pacific Synthetic Biology Market Outlook, By End-use, Value (US$ Bn), 2019 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Biotechnology & Pharmaceutical Companies
      • 6.4.1.2. Academic & Government Research Institutes
      • 6.4.1.3. Other End-uses
  • 6.5. Asia Pacific Synthetic Biology Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 6.5.1.2. China Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 6.5.1.3. China Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 6.5.1.4. China Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 6.5.1.5. Japan Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 6.5.1.6. Japan Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 6.5.1.7. Japan Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 6.5.1.8. Japan Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 6.5.1.9. South Korea Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 6.5.1.10. South Korea Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 6.5.1.11. South Korea Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 6.5.1.12. South Korea Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 6.5.1.13. India Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 6.5.1.14. India Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 6.5.1.15. India Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 6.5.1.16. India Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 6.5.1.17. Southeast Asia Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 6.5.1.18. Southeast Asia Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 6.5.1.19. Southeast Asia Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 6.5.1.20. Southeast Asia Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 6.5.1.21. Rest of Asia Pacific Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 6.5.1.22. Rest of Asia Pacific Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 6.5.1.23. Rest of Asia Pacific Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 6.5.1.24. Rest of Asia Pacific Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
    • 6.5.2. Market Attractiveness Analysis

7. Latin America Synthetic Biology Market Outlook, 2019 - 2031

  • 7.1. Latin America Synthetic Biology Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Healthcare
        • 7.1.1.1.1. Clinical
        • 7.1.1.1.2. Non-Clinical Research
      • 7.1.1.2. Non-Healthcare
        • 7.1.1.2.1. Biotech Crops
        • 7.1.1.2.2. Speciality Chemicals
        • 7.1.1.2.3. Bio-Fuels
  • 7.2. Latin America Synthetic Biology Market Outlook, By Product Type, Value (US$ Bn), 2019 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Oligonucleotide/Oligo pools and Synthetic DNA
      • 7.2.1.2. Enzymes
      • 7.2.1.3. Cloning Technologies Kits
      • 7.2.1.4. Xeno-nucleic Acids
      • 7.2.1.5. Chassis Organism
  • 7.3. Latin America Synthetic Biology Market Outlook, By Technology, Value (US$ Bn), 2019 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. NGS
      • 7.3.1.2. PCR
      • 7.3.1.3. Genome Editing
      • 7.3.1.4. Bioprocessing Technology
      • 7.3.1.5. Other Technologies
  • 7.4. Latin America Synthetic Biology Market Outlook, By End-use, Value (US$ Bn), 2019 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Biotechnology & Pharmaceutical Companies
      • 7.4.1.2. Academic & Government Research Institutes
      • 7.4.1.3. Other End-uses
  • 7.5. Latin America Synthetic Biology Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 7.5.1.2. Brazil Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 7.5.1.3. Brazil Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 7.5.1.4. Brazil Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 7.5.1.5. Mexico Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 7.5.1.6. Mexico Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 7.5.1.7. Mexico Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 7.5.1.8. Mexico Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 7.5.1.9. Argentina Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 7.5.1.10. Argentina Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 7.5.1.11. Argentina Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 7.5.1.12. Argentina Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 7.5.1.13. Rest of Latin America Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 7.5.1.14. Rest of Latin America Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 7.5.1.15. Rest of Latin America Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 7.5.1.16. Rest of Latin America Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
    • 7.5.2. Market Attractiveness Analysis

8. Middle East & Africa Synthetic Biology Market Outlook, 2019 - 2031

  • 8.1. Middle East & Africa Synthetic Biology Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Healthcare
        • 8.1.1.1.1. Clinical
        • 8.1.1.1.2. Non-Clinical Research
      • 8.1.1.2. Non-Healthcare
        • 8.1.1.2.1. Biotech Crops
        • 8.1.1.2.2. Speciality Chemicals
        • 8.1.1.2.3. Bio-Fuels
  • 8.2. Middle East & Africa Synthetic Biology Market Outlook, By Product Type, Value (US$ Bn), 2019 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Oligonucleotide/Oligo pools and Synthetic DNA
      • 8.2.1.2. Enzymes
      • 8.2.1.3. Cloning Technologies Kits
      • 8.2.1.4. Xeno-nucleic Acids
      • 8.2.1.5. Chassis Organism
  • 8.3. Middle East & Africa Synthetic Biology Market Outlook, By Technology, Value (US$ Bn), 2019 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. NGS
      • 8.3.1.2. PCR
      • 8.3.1.3. Genome Editing
      • 8.3.1.4. Bioprocessing Technology
      • 8.3.1.5. Other Technologies
  • 8.4. Middle East & Africa Synthetic Biology Market Outlook, By End-use, Value (US$ Bn), 2019 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Biotechnology & Pharmaceutical Companies
      • 8.4.1.2. Academic & Government Research Institutes
      • 8.4.1.3. Other End-uses
  • 8.5. Middle East & Africa Synthetic Biology Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 8.5.1.2. GCC Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 8.5.1.3. GCC Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 8.5.1.4. GCC Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 8.5.1.5. South Africa Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 8.5.1.6. South Africa Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 8.5.1.7. South Africa Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 8.5.1.8. South Africa Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 8.5.1.9. Egypt Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 8.5.1.10. Egypt Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 8.5.1.11. Egypt Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 8.5.1.12. Egypt Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 8.5.1.13. Nigeria Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 8.5.1.14. Nigeria Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 8.5.1.15. Nigeria Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 8.5.1.16. Nigeria Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Synthetic Biology Market By Application, Value (US$ Bn), 2019 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Synthetic Biology Market By Product Type, Value (US$ Bn), 2019 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Synthetic Biology Market By Technology, Value (US$ Bn), 2019 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Synthetic Biology Market By End-use, Value (US$ Bn), 2019 - 2031
    • 8.5.2. Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Technology vs By Product Type Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Bota Biosciences
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Codexis, Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Creative Biogene
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Creative Enzymes
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. EnBiotix, Inc.
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Eurofins Scientific
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Illumina
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Merck
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. New England Biolabs
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Novozymes
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!